Trial Profile
Non-Interventional Trial of the Safe Use of Aerius in Pediatric Patients With Allergic Rhinitis or Chronic Idiopathic Urticaria.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Feb 2022
Price :
$35
*
At a glance
- Drugs Desloratadine (Primary)
- Indications Allergic rhinitis; Urticaria
- Focus Adverse reactions
- Sponsors Organon
- 02 Jun 2010 Actual number of patientsadded to 100 as reported by ClinicalTrials.gov.
- 15 Aug 2008 New trial record.